CIK 0001117480
CMRX CHIMERIX INC
Insider trading from SEC Form 4. Last filing Apr 21, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
14
with a Form 4 at this company
Signals
Open-market buys and sells at CHIMERIX INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | Michael Albert Alrutz SVP AND GENERAL COUNSEL sell | $7,226 1,600 shares | -1% | - | |
| 26Weak | Michael T. Andriole PRESIDENT AND CEO sell | $33k 7,370 shares | -1% | - | |
| 17Weak | Michelle LaSpaluto CHIEF FINANCIAL OFFICER sell | $10k 2,260 shares | -1% | - | |
| 10Weak | David Jakeman VP OF FINANCE AND ACCOUNTING sell | $1,360 300 shares | -0% | - | |
| 10Weak | Allen S. Melemed CHIEF MEDICAL OFFICER sell | $14k 3,065 shares | -2% | - | |
| 20Weak | Michael T. Andriole PRESIDENT AND CEO sell | $9,636 2,350 shares | -0% | - | |
| 17Weak | Michelle LaSpaluto CHIEF FINANCIAL OFFICER sell | $4,172 1,015 shares | -1% | - | |
| 10Weak | David Jakeman VP OF FINANCE AND ACCOUNTING sell | $11k 2,800 shares | -2% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 21, 2025 | Pratik S Multani director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Fred A Middleton director | DDisposition to issuer Common Stockindirect: Fred A. Middleton Separate Property Trust | -40,000 | $8.55 | $342k | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Martha J Demski director | DDisposition to issuer Common Stockindirect: By the Martha J. Demski Trust u/a 10/01/94 | -72,055 | $8.55 | $616k | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Victoria Vakiener director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Marc D Kozin director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -100,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michelle LaSpaluto CHIEF FINANCIAL OFFICER | DDisposition to issuer Common Stock | -181,541 | $8.55 | $1.6M | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Lisa Lynn Decker director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -100,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Allen S. Melemed CHIEF MEDICAL OFFICER | DDisposition to issuer Common Stock | -173,852 | $8.55 | $1.5M | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Robert J. Meyer director | DDisposition to issuer Common Stock | -35,150 | $8.55 | $301k | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael T. Andriole PRESIDENT AND CEO | DDisposition to issuer Common Stock | -630,828 | $8.55 | $5.4M | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael Albert Alrutz SVP AND GENERAL COUNSEL | DDisposition to issuer Common Stock | -216,689 | $8.55 | $1.9M | 0 | Apr 21, 2025 |
| Apr 21, 2025 | David Jakeman VP OF FINANCE AND ACCOUNTING | DDisposition to issuer Common Stock | -156,209 | $8.55 | $1.3M | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Thomas J Riga COO and CCO | DDisposition to issuer Common Stock | -60,828 | $8.55 | $520k | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael A. Sherman Chief Executive Officer | DDisposition to issuer Common Stockindirect: By Michael A Sherman Trust Dated June 29, 2007 | -87,000 | $8.55 | $744k | 0 | Apr 21, 2025 |
| Apr 21, 2025 | David Jakeman VP OF FINANCE AND ACCOUNTING | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -10,150 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael Albert Alrutz SVP AND GENERAL COUNSEL | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -178,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Martha J Demski director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -9,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Pratik S Multani director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -35,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Allen S. Melemed CHIEF MEDICAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -400,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Lisa Lynn Decker director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Marc D Kozin director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Thomas J Riga COO and CCO | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -800,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Fred A Middleton director | DDisposition to issuer Common Stockindirect: Middleton Childrens 2015 Irrevocable Trust | -60,000 | $8.55 | $513k | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michelle LaSpaluto CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -18,700 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael T. Andriole PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -450,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Robert J. Meyer director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael A. Sherman Chief Executive Officer | DDisposition to issuer Common Stockindirect: By Sherman Investors LLC | -102,995 | $8.55 | $881k | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Victoria Vakiener director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -35,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael A. Sherman Chief Executive Officer | DDisposition to issuer Common Stock | -233,413 | $8.55 | $2.0M | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Thomas J Riga COO and CCO | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -325,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | David Jakeman VP OF FINANCE AND ACCOUNTING | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Allen S. Melemed CHIEF MEDICAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -190,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Victoria Vakiener director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -50,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Robert J. Meyer director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -21,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael Albert Alrutz SVP AND GENERAL COUNSEL | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -15,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Pratik S Multani director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -35,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Martha J Demski director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -9,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michelle LaSpaluto CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -1,500 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Fred A Middleton director | DDisposition to issuer Common Stockindirect: See footnote | -2,776,093 | $8.55 | $24M | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael T. Andriole PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -192,500 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael Albert Alrutz SVP AND GENERAL COUNSEL | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -45,750 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael T. Andriole PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -250,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Allen S. Melemed CHIEF MEDICAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -240,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | David Jakeman VP OF FINANCE AND ACCOUNTING | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -7,200 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Robert J. Meyer director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -21,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Fred A Middleton director | DDisposition to issuer Common Stockindirect: See footnote | -531,861 | $8.55 | $4.5M | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael A. Sherman Chief Executive Officer | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -1,150,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Victoria Vakiener director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Pratik S Multani director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -50,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Martha J Demski director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -21,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michelle LaSpaluto CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -15,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael T. Andriole PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -300,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Allen S. Melemed CHIEF MEDICAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -154,260 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | David Jakeman VP OF FINANCE AND ACCOUNTING | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -1,250 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Robert J. Meyer director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -35,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Pratik S Multani director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael Albert Alrutz SVP AND GENERAL COUNSEL | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -135,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Victoria Vakiener director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Martha J Demski director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -21,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michelle LaSpaluto CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -1,250 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Fred A Middleton director | DDisposition to issuer Common Stock | -207,523 | $8.55 | $1.8M | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael A. Sherman Chief Executive Officer | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -632,500 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael Albert Alrutz SVP AND GENERAL COUNSEL | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -176,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Allen S. Melemed CHIEF MEDICAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -168,750 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael T. Andriole PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -192,825 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Robert J. Meyer director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -35,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | David Jakeman VP OF FINANCE AND ACCOUNTING | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -9,360 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Fred A Middleton director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael A. Sherman Chief Executive Officer | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -700,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Pratik S Multani director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michelle LaSpaluto CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -13,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Martha J Demski director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -21,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Allen S. Melemed CHIEF MEDICAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -275,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael T. Andriole PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -150,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Robert J. Meyer director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -50,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | David Jakeman VP OF FINANCE AND ACCOUNTING | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Fred A Middleton director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -21,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael A. Sherman Chief Executive Officer | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -875,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michelle LaSpaluto CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -8,098 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Martha J Demski director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -35,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael Albert Alrutz SVP AND GENERAL COUNSEL | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -165,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael Albert Alrutz SVP AND GENERAL COUNSEL | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -170,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael T. Andriole PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -502,500 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Robert J. Meyer director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | David Jakeman VP OF FINANCE AND ACCOUNTING | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -28,320 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Fred A Middleton director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -21,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael A. Sherman Chief Executive Officer | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -557,050 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michelle LaSpaluto CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -48,438 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Martha J Demski director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -35,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Martha J Demski director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -50,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael Albert Alrutz SVP AND GENERAL COUNSEL | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -200,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Robert J. Meyer director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael T. Andriole PRESIDENT AND CEO | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -900,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | David Jakeman VP OF FINANCE AND ACCOUNTING | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -1,500 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Fred A Middleton director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -35,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael A. Sherman Chief Executive Officer | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michelle LaSpaluto CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -62,067 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Martha J Demski director | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | Michael Albert Alrutz SVP AND GENERAL COUNSEL | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -128,550 | - | - | 0 | Apr 21, 2025 |
| Apr 21, 2025 | David Jakeman VP OF FINANCE AND ACCOUNTING | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -30,000 | - | - | 0 | Apr 21, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Michael Albert AlrutzSVP AND GENERAL COUNSEL
- Michael T. AndriolePRESIDENT AND CEO
- Martha J Demskidirector
- Lisa Lynn Deckerofficer, director
- David JakemanVP OF FINANCE AND ACCOUNTING
- Marc D Kozindirector
- Michelle LaSpalutoCHIEF FINANCIAL OFFICER
- Fred A Middletondirector, owner
- Allen S. MelemedCHIEF MEDICAL OFFICER
- Robert J. Meyerdirector
- Pratik S Multaniofficer, director
- Thomas J RigaCOO and CCO
- Michael A. ShermanChief Executive Officer
- Victoria Vakienerdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.